View Future GrowthLocus Cell 과거 순이익 실적과거 기준 점검 0/6Locus Cell 의 수입은 연평균 -39.1%의 비율로 감소해 온 반면, Life Sciences 산업은 연평균 6.3%의 비율로 증가했습니다. 매출은 연평균 83.9%의 비율로 증가해 왔습니다.핵심 정보-39.08%순이익 성장률6.31%주당순이익(EPS) 성장률Life Sciences 산업 성장률5.47%매출 성장률83.87%자기자본이익률-11.71%순이익률-1,425.20%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Apr 05Full year 2025 earnings released: NT$0.91 loss per share (vs NT$0.56 loss in FY 2024)Full year 2025 results: NT$0.91 loss per share (further deteriorated from NT$0.56 loss in FY 2024). Net loss: NT$181.5m (loss widened 61% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 16Full year 2023 earnings released: NT$0.48 loss per share (vs NT$0.27 loss in FY 2022)Full year 2023 results: NT$0.48 loss per share (further deteriorated from NT$0.27 loss in FY 2022). Net loss: NT$96.9m (loss widened 81% from FY 2022).모든 업데이트 보기Recent updatesNew Risk • Apr 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$601m free cash flow). Earnings have declined by 39% per year over the past 5 years. Revenue is less than US$1m (NT$13m revenue, or US$400k). Minor Risk Share price has been volatile over the past 3 months (9.1% average weekly change).Reported Earnings • Apr 05Full year 2025 earnings released: NT$0.91 loss per share (vs NT$0.56 loss in FY 2024)Full year 2025 results: NT$0.91 loss per share (further deteriorated from NT$0.56 loss in FY 2024). Net loss: NT$181.5m (loss widened 61% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.공시 • Mar 10Locus Cell Co., Ltd., Annual General Meeting, Jun 25, 2026Locus Cell Co., Ltd., Annual General Meeting, Jun 25, 2026. Location: 1 floor no,152, sec.1 ta t`ung rd., sijhih district, new taipei city TaiwanNew Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$572m free cash flow). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (NT$5.2m revenue, or US$165k). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).New Risk • Sep 18New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -NT$572m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$572m free cash flow). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (NT$5.2m revenue, or US$172k). Minor Risk Share price has been volatile over the past 3 months (7.4% average weekly change).New Risk • Aug 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 43% per year over the past 5 years. Revenue is less than US$1m (NT$2.4m revenue, or US$77k). Minor Risk Share price has been volatile over the past 3 months (6.2% average weekly change).New Risk • Mar 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (NT$1.0m revenue, or US$31k). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.0% average weekly change).공시 • Mar 10Locus Cell Co., Ltd., Annual General Meeting, Jun 20, 2025Locus Cell Co., Ltd., Annual General Meeting, Jun 20, 2025. Location: 1 floor no,152, sec.1 ta t`ung rd., sijhih district, new taipei city TaiwanNew Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (NT$1.0m revenue, or US$32k). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).공시 • Nov 16Locus Cell Co., Ltd. Announces Committee AppointmentsOn November 15, 2024, Locus Cell Co., Ltd. announced two additional independent directors to its audit committee. Name of the new position holder: Independent director, Bao-Huei Huang, Director of Tatung Company; Independent director, Chih-Cheng Wang, Professor, College of Law, Chinese Culture University. Reason for the change: By-election of independent directors. Effective date of the new member: November 15, 2024.공시 • Sep 12Locus Cell Co., Ltd. Announces Resignation of Kuan-Ling Lai as Natural-Person DirectorLocus Cell Co., Ltd. announced resignation of Kuan-Ling Lai as natural-person director. Resume of the previous position holder: Special Assistant to the Deputy Chairman, Tatung Company. Reason for the change:Busy on work. Effective date of resignation is September 10, 2024.공시 • Aug 30Locus Cell Co., Ltd. Announces Resignation of Fang-Chen Kao as Director, Effective August 30, 2024Locus Cell Co., Ltd. announced that the resignation of natural-person director of the company the company's 2024 regular shareholders meeting. Title and name of the previous position holder: Director, Fang-Chen Kao. Resume of the previous position holder: Chairman of Yu Meng Biomedical Co., Ltd. The company received the resignation letter on August 29, 2024, and the effective date of resignation is August 30, 2024.공시 • Jun 27Locus Cell Co., Ltd. Appoints Kun-Ying, Tsai as Chief Operating Officer, Effective July 15, 2024Locus Cell Co., Ltd. announced the board of directors has resolved to appoint a chief operating officer. Name, title, and resume of the new position holder: Mr. Kun-Ying, Tsai. Type of change: New replacement. Effective date: July 15, 2024.공시 • May 25+ 1 more updateLocus Cell Co., Ltd. Announces Board ChangesLocus Cell Co., Ltd. announced the election of chairman of the board of directors of the company. Position: Chairperson. Name of the previous position holder: Hong-Nerng Ho. Resume of the previous position holder: Adviser of Taipei Medical University. Name of the new position holder: Jiunn-Rong Chiou. Resume of the new position holder: Professor of Economics, National Central University. Circumstances of change: Term expired. Reason for the change: Comprehensive re-election of directors (including independent directors). Effective date of the new appointment: May 24, 2024.Reported Earnings • Apr 16Full year 2023 earnings released: NT$0.48 loss per share (vs NT$0.27 loss in FY 2022)Full year 2023 results: NT$0.48 loss per share (further deteriorated from NT$0.27 loss in FY 2022). Net loss: NT$96.9m (loss widened 81% from FY 2022).New Risk • Mar 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 100% over the past year. Revenue is less than US$1m. Minor Risk Share price has been volatile over the past 3 months (6.4% average weekly change).공시 • Mar 08Locus Cell Co., Ltd., Annual General Meeting, May 24, 2024Locus Cell Co., Ltd., Annual General Meeting, May 24, 2024. Location: 1F No. 152 Sec. 1 Datong Rd. Xizhi District, New Taipei City (Yi Yuan Garden, Fushin Hotel) New Taipei City Taiwan Agenda: To consider 2023 Business Report; Audit Committees Review Report on the 2023 Accounting Final Statements; Report on implementation of the Companys Sound Business Plan; Report on revision of certain articles in the Company; Ratification of the Business Report and Financial Statements for 2023; Ratification of the Loss Compensation Plan for 2023; and to discuss other matters.공시 • Dec 29Locus Cell Co., Ltd. Approves Establishment of Information Security Committee and Appoints First Committee MembersLocus Cell Co., Ltd. approved the establishment of the Information Security Committee and appointed first committee members. Name of the new position holder: Wen-Yuan Lin, Kuo-Bin Lin, Chun-Nong Cheng, Shih-Chia Lin, Yeong-Sung Lin. Resume of the new position holder: Wen-Yuan Lin, Independent Director of Locus Cell; Kuo-Bin Lin, Independent Director of Locus Cell; Chun-Nong Cheng, Independent Director of Locus Cell; Shih-Chia Lin, Director and Chief Executive Officer of Locus Cell; Yeong-Sung Lin, Information Security Consultant of Locus Cell. Effective date of the new member is December 27, 2023.매출 및 비용 세부 내역Locus Cell가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이TPEX:6891 매출, 비용 및 순이익 (TWD Millions)날짜매출순이익일반관리비연구개발비31 Dec 2513-182928830 Sep 259-173908630 Jun 255-164888431 Mar 254-148888231 Dec 242-113837830 Sep 242-128837530 Jun 241-109847131 Mar 241-91806531 Dec 230-97796130 Sep 230-77765630 Jun 231-72684931 Mar 231-66634131 Dec 221-53613230 Sep 221-44572130 Jun 220-54571331 Mar 220-4444631 Dec 210-35322양질의 수익: 6891 은(는) 현재 수익성이 없습니다.이익 마진 증가: 6891는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 6891은 수익성이 없으며 지난 5년 동안 손실이 연평균 39.1% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 6891의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: 6891은 수익성이 없어 지난 해 수익 성장률을 Life Sciences 업계(19.1%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: 6891는 현재 수익성이 없으므로 자본 수익률이 음수(-11.71%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/27 17:15종가2026/06/26 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Locus Cell Co., Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Apr 05Full year 2025 earnings released: NT$0.91 loss per share (vs NT$0.56 loss in FY 2024)Full year 2025 results: NT$0.91 loss per share (further deteriorated from NT$0.56 loss in FY 2024). Net loss: NT$181.5m (loss widened 61% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 16Full year 2023 earnings released: NT$0.48 loss per share (vs NT$0.27 loss in FY 2022)Full year 2023 results: NT$0.48 loss per share (further deteriorated from NT$0.27 loss in FY 2022). Net loss: NT$96.9m (loss widened 81% from FY 2022).
New Risk • Apr 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$601m free cash flow). Earnings have declined by 39% per year over the past 5 years. Revenue is less than US$1m (NT$13m revenue, or US$400k). Minor Risk Share price has been volatile over the past 3 months (9.1% average weekly change).
Reported Earnings • Apr 05Full year 2025 earnings released: NT$0.91 loss per share (vs NT$0.56 loss in FY 2024)Full year 2025 results: NT$0.91 loss per share (further deteriorated from NT$0.56 loss in FY 2024). Net loss: NT$181.5m (loss widened 61% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.
공시 • Mar 10Locus Cell Co., Ltd., Annual General Meeting, Jun 25, 2026Locus Cell Co., Ltd., Annual General Meeting, Jun 25, 2026. Location: 1 floor no,152, sec.1 ta t`ung rd., sijhih district, new taipei city Taiwan
New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$572m free cash flow). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (NT$5.2m revenue, or US$165k). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).
New Risk • Sep 18New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -NT$572m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$572m free cash flow). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (NT$5.2m revenue, or US$172k). Minor Risk Share price has been volatile over the past 3 months (7.4% average weekly change).
New Risk • Aug 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 43% per year over the past 5 years. Revenue is less than US$1m (NT$2.4m revenue, or US$77k). Minor Risk Share price has been volatile over the past 3 months (6.2% average weekly change).
New Risk • Mar 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (NT$1.0m revenue, or US$31k). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.0% average weekly change).
공시 • Mar 10Locus Cell Co., Ltd., Annual General Meeting, Jun 20, 2025Locus Cell Co., Ltd., Annual General Meeting, Jun 20, 2025. Location: 1 floor no,152, sec.1 ta t`ung rd., sijhih district, new taipei city Taiwan
New Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (NT$1.0m revenue, or US$32k). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).
공시 • Nov 16Locus Cell Co., Ltd. Announces Committee AppointmentsOn November 15, 2024, Locus Cell Co., Ltd. announced two additional independent directors to its audit committee. Name of the new position holder: Independent director, Bao-Huei Huang, Director of Tatung Company; Independent director, Chih-Cheng Wang, Professor, College of Law, Chinese Culture University. Reason for the change: By-election of independent directors. Effective date of the new member: November 15, 2024.
공시 • Sep 12Locus Cell Co., Ltd. Announces Resignation of Kuan-Ling Lai as Natural-Person DirectorLocus Cell Co., Ltd. announced resignation of Kuan-Ling Lai as natural-person director. Resume of the previous position holder: Special Assistant to the Deputy Chairman, Tatung Company. Reason for the change:Busy on work. Effective date of resignation is September 10, 2024.
공시 • Aug 30Locus Cell Co., Ltd. Announces Resignation of Fang-Chen Kao as Director, Effective August 30, 2024Locus Cell Co., Ltd. announced that the resignation of natural-person director of the company the company's 2024 regular shareholders meeting. Title and name of the previous position holder: Director, Fang-Chen Kao. Resume of the previous position holder: Chairman of Yu Meng Biomedical Co., Ltd. The company received the resignation letter on August 29, 2024, and the effective date of resignation is August 30, 2024.
공시 • Jun 27Locus Cell Co., Ltd. Appoints Kun-Ying, Tsai as Chief Operating Officer, Effective July 15, 2024Locus Cell Co., Ltd. announced the board of directors has resolved to appoint a chief operating officer. Name, title, and resume of the new position holder: Mr. Kun-Ying, Tsai. Type of change: New replacement. Effective date: July 15, 2024.
공시 • May 25+ 1 more updateLocus Cell Co., Ltd. Announces Board ChangesLocus Cell Co., Ltd. announced the election of chairman of the board of directors of the company. Position: Chairperson. Name of the previous position holder: Hong-Nerng Ho. Resume of the previous position holder: Adviser of Taipei Medical University. Name of the new position holder: Jiunn-Rong Chiou. Resume of the new position holder: Professor of Economics, National Central University. Circumstances of change: Term expired. Reason for the change: Comprehensive re-election of directors (including independent directors). Effective date of the new appointment: May 24, 2024.
Reported Earnings • Apr 16Full year 2023 earnings released: NT$0.48 loss per share (vs NT$0.27 loss in FY 2022)Full year 2023 results: NT$0.48 loss per share (further deteriorated from NT$0.27 loss in FY 2022). Net loss: NT$96.9m (loss widened 81% from FY 2022).
New Risk • Mar 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 100% over the past year. Revenue is less than US$1m. Minor Risk Share price has been volatile over the past 3 months (6.4% average weekly change).
공시 • Mar 08Locus Cell Co., Ltd., Annual General Meeting, May 24, 2024Locus Cell Co., Ltd., Annual General Meeting, May 24, 2024. Location: 1F No. 152 Sec. 1 Datong Rd. Xizhi District, New Taipei City (Yi Yuan Garden, Fushin Hotel) New Taipei City Taiwan Agenda: To consider 2023 Business Report; Audit Committees Review Report on the 2023 Accounting Final Statements; Report on implementation of the Companys Sound Business Plan; Report on revision of certain articles in the Company; Ratification of the Business Report and Financial Statements for 2023; Ratification of the Loss Compensation Plan for 2023; and to discuss other matters.
공시 • Dec 29Locus Cell Co., Ltd. Approves Establishment of Information Security Committee and Appoints First Committee MembersLocus Cell Co., Ltd. approved the establishment of the Information Security Committee and appointed first committee members. Name of the new position holder: Wen-Yuan Lin, Kuo-Bin Lin, Chun-Nong Cheng, Shih-Chia Lin, Yeong-Sung Lin. Resume of the new position holder: Wen-Yuan Lin, Independent Director of Locus Cell; Kuo-Bin Lin, Independent Director of Locus Cell; Chun-Nong Cheng, Independent Director of Locus Cell; Shih-Chia Lin, Director and Chief Executive Officer of Locus Cell; Yeong-Sung Lin, Information Security Consultant of Locus Cell. Effective date of the new member is December 27, 2023.